Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Drugs Made In America Acquisition II Corp. Unit DMIIU NASDAQ

NASDAQ Global Select • Financial Services • Asset Management • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Drugs Made In America Acquisition II Corp. Unit (DMIIU) is a Asset Management company in the Financial Services sector, currently trading at $10.06.

Stock Chart & Stats

Market Data
52-Week Range9.935-10.8
Volume1K
Avg Volume (30D)3.69K
Market Cap$633.96M
Beta (1Y)0.24
IPO Date2025-09-25
Employees2
CEORoger Bendelac
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINKYG2851K1206

Price Chart

Track all markets on TradingView
DMIIU
Drugs Made In America Acquisition II Corp. Unit ↗  ·  NASDAQ Global Select
Financial Services • Asset Management
9.94 52WK RANGE 10.80

People Also View

GAM
GAM
General American Investors Company, Inc.
$62.90
+0.61%
 NCDL
NCDL
Nuveen Churchill Direct Lending Corp.
$14.42
+2.85%
 GAIN
GAIN
Gladstone Investment Corporation
$15.36
+1.45%
 MSIF
MSIF
MSC Income Fund, Inc.
$12.89
+1.82%
 NEWT
NEWT
NewtekOne, Inc.
$12.73
+1.35%
 EIC
EIC
Eagle Point Income Company Inc.
$9.82
+1.45%
 OCCI
OCCI
OFS Credit Company, Inc.
$2.98
-1.65%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$166.82
+1.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message